For the quarter ending 2026-03-31, DERM made $15,961K in revenue. -$2,230K in net income. Net profit margin of -13.97%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 15,961 | 16,079 | 17,631 | 15,009 |
| Cost of goods sold - (excluding amortization of acquired intangible assets) | 6,218 | 5,603* | 5,755 | 4,939 |
| Amortization of acquired intangible assets | 1,126 | 1,065 | 1,064 | 1,064 |
| Research and development | - | -9* | 287 | - |
| Selling, general and administrative | 10,109 | 9,863 | 12,054 | 11,882 |
| Total operating expenses | 17,453 | 16,522 | 19,160 | 17,885 |
| Loss from operations | -1,492 | -443 | -1,529 | -2,876 |
| Interest income | 157 | 148 | 154 | 138 |
| Interest expense | 892 | 933 | 937 | 937 |
| Foreign exchange transaction losses | -3 | -19 | -3 | -61 |
| Total other expense | -738 | -804 | -786 | -860 |
| Loss before income taxes | -2,230 | -1,247 | -2,315 | -3,736 |
| State | - | 15 | - | - |
| Total current | - | 15* | - | - |
| Federal | - | -556* | - | - |
| State | - | -11* | - | - |
| Total deferred | - | -567* | - | - |
| Valuation allowance | - | 552* | - | - |
| Income tax expense | - | 0 | - | 60 |
| Net loss | -2,230 | -1,247 | -2,315 | -3,796 |
| Basic EPS | -0.08 | -0.046 | -0.09 | -0.16 |
| Diluted EPS | -0.08 | -0.046 | -0.09 | -0.16 |
| Basic Average Shares | 27,305,028 | 27,130,932 | 24,959,114 | 23,290,806 |
| Diluted Average Shares | 27,305,028 | 27,130,932 | 24,959,114 | 23,290,806 |
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)